The Retinal Degeneration Fund (RD Fund) is driving the future of retinal innovation through strategic investments to accelerate the development of novel therapeutics for inherited retinal diseases (IRDs) and dry Age-related Macular Degeneration (dry AMD). 

The RD Fund was designed to bridge the critical funding gap between discovery stage research and drug development.